Individual Study / The AFLMU Biobank LMU

The AFLMU Biobank LMU

The AFLMU Biobank LMU

Initiatives -
The Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study contributes to the spectrum of disease by adding carefully characterized patients with atrial fibrillation. Atrial fibrillation, one of the most common human arrhythmias confers major morbidity, mortality and health care cost, and has been demonstrated to be caused and influenced by genetic and -omics factors. Particularly, AFLMU enrolled patients with an early onset of atrial fibrillation to increase the genetic burden on disease pathophysiology. All patients were recruited applying standardized protocols to maintain homogeneity in data and DNA quality. **nhlbigeneticdata@nhlbi.nih.gov**
Start Year
2007
Funding
HTCR Foundation
Visit The AFLMU Biobank LMU

Design

Study design
Patients' cohort

Marker Paper

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
350
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other